1st Trial of Anesthetic Ketamine for Depression in Parkinson’s Wins $2M

1st Trial of Anesthetic Ketamine for Depression in Parkinson’s Wins $2M

312550

1st Trial of Anesthetic Ketamine for Depression in Parkinson’s Wins $2M

Two scientists at Yale University were awarded $2 million from the Michael J. Fox Foundation to conduct the first clinical trial investigating the use of ketamine — a powerful anesthetic — as a treatment for depression in people with Parkinson’s disease. The study will be led by Sophie E. Holmes, PhD, assistant professor of psychiatry and neurology, in collaboration with Gerard Sanacora, MD, PhD, a psychiatry professor, both at the Yale School of Medicine, the…

You must be logged in to read/download the full post.